Insmed Incorporated NMS · INSM

Nasdaq-100 Index® June 2026 Quarterly Changes

GlobeNewswire Inc. · 37d ago

Nasdaq 100 Climbs Records, Oil Extends Drop As Iran Weighs Hormuz Deal: Stock Market Today

Benzinga · 72d ago

Interstitial Lung Disease Market to Witness Accelerated Growth at a CAGR of 8.7% During the Forecast Period (2026–2036) Due to the Launch of Emerging Therapies | DelveInsight

GlobeNewswire Inc. · 101d ago

This New $193 Million Bet Targets a Biotech With $689 Million in Revenue and a Potential Turnaround Story

The Motley Fool · 119d ago

Stock Market Today, Jan. 6: Alumis Shares Surge on Positive Phase 3 Psoriasis Data for Envudeucitinib

The Motley Fool · 193d ago

Nike, Insmed, And Arm Are Among Top 10 Large Cap Losers Last Week (Dec. 15-Dec. 19): Are the Others in Your Portfolio?

Benzinga · 209d ago

30% of Billionaire Stanley Druckenmiller's Portfolio Is Invested in These 3 Biotech Stocks

The Motley Fool · 231d ago

DPP1 Inhibitor Market Set to Reach New Heights in the Coming Decade | DelveInsight

GlobeNewswire Inc. · 313d ago

Non-cystic Fibrosis Bronchiectasis Market Ready to Shift Gears with the Entry of First DPP1 Blocker | DelveInsight

GlobeNewswire Inc. · 327d ago

Pulmonary Hypertension associated with Interstitial Lung Disease Market to Witness Upsurge in Growth During the Forecast Period (2025–2034) | DelveInsight

GlobeNewswire Inc. · 338d ago

Russell Rebalance: 3 Stocks Ready to Move Higher

Investing.com · 393d ago

Insmed's Pulmonary Hypertension Drug Data Exceeded Even Bullish Outlook, Analysts Boost Price Forecast

Benzinga · 402d ago

8MM Bronchiectasis Market Opportunity Assessment and Forecasts, 2033 - Pipeline Innovations Expected to Add $1.8 Billion in Bronchiectasis Market Sales

GlobeNewswire Inc. · 422d ago

Bronchiectasis Market to Show Positive Growth at a CAGR of 13.7% by 2034 | DelveInsight

GlobeNewswire Inc. · 543d ago

Evolving Landscape of Cardiology Segment: Key Market Insights of Latest Published Rare Cardiovascular Diseases Report — Giant-Cell Arteritis, Pulmonary Arterial Hypertension, and Restrictive Cardiomyopathy | DelveInsight

GlobeNewswire Inc. · 550d ago

A Russell 2000 Bull Market Could Be Coming: 1 Spectacular BlackRock ETF to Buy Hand Over Fist Before It Gets Here

The Motley Fool · 552d ago

Groundbreaking Insights Unveiled in Non-Cystic Fibrosis Bronchiectasis Pipeline Report

GlobeNewswire Inc. · 597d ago

High Levels of Cooperation, Care Drive Employees to Give Extra at the Best Small and Medium Workplaces

GlobeNewswire Inc. · 689d ago

Insmed Unusual Options Activity For July 11 - Benzinga

Benzinga · 737d ago

Wall Street Breakfast: The Week Ahead

Seeking Alpha · 748d ago

Insmed (INSM) Stock Soars 118% on Upbeat Lung Disease Drug Data

Zacks Investment Research · 780d ago

Insmed (INSM) Beats on Q1 Earnings, Posts Upbeat Pipeline Updates

Zacks Investment Research · 799d ago

Insmed (INSM) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates

Zacks Investment Research · 800d ago

Insmed (INSM) Reports Q1 Loss, Lags Revenue Estimates

Zacks Investment Research · 800d ago

Should You Buy Insmed (INSM) Ahead of Earnings?

Zacks Investment Research · 801d ago